Hostname: page-component-848d4c4894-ndmmz Total loading time: 0 Render date: 2024-05-18T17:57:43.764Z Has data issue: false hasContentIssue false
  • English
  • Français

Influenza Pandemic: A Perspective

Published online by Cambridge University Press:  28 June 2012

Geert Seynaeve
Geert Seynaeve*
Affiliation:
Deputy Editor, Prehospital and Disaster Medicine, Brussels, Belgium
*
geert.seynaeve@attentia.be
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Information
Prehospital and Disaster Medicine , Volume 24 , Issue 6 , December 2009 , pp. 473 - 477
Copyright
Copyright © World Association for Disaster and Emergency Medicine 2009

References

1. Seynaeve, G: The 1999 dioxin and Coca Cola crisis. A case study in Public Health Crises. Brussels, Belgium. Ecomed 2003.Google Scholar
2. Murray, CJL, Lopez, AD: Evidence-based health policy—Lessons from the global burden of disease study. Science 1996;274:740–743.CrossRefGoogle ScholarPubMed
3. World Health Organization: The World Health Report 2008: Geneva: WHO, 2008.Google Scholar
4. International Federation of Red Cross and Red Crescent: The World Disasters Report 2000. Focus on Public Health. Geneva: IFRC, 2000, p 240.Google Scholar
5. World Health Organization (WHO): The World Health Report 2008: Primary health Care. Now More Than Ever. Geneva: WHO, 2008.Google Scholar
6. Mathers, CD, Loncar, D: Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3(11):2011–2030.CrossRefGoogle ScholarPubMed
7. Norris, JN: Social inequalities undiminished. Amstelveen, The Netherlands. T Soc Geneeskunde 1980;58 Suppl:13–18.Google Scholar
8. Knobloch, J, Finke, EJ, Domres, B: Seuchenhygien and Bekämpfung. In: Schutzkommission beim Bundesminister des Innern. Katastrophenmedizin. Leitfaden für die ärtzliche Versorgung im Katastrophenfall. Berlin: Auflage, 2002, pp 180–223.Google Scholar
9. Sasse, J: Biologische Gefahren. Beiträge zum Bevölkerungsschutz. Bonn, BBK: Germany: 2005, p 394.Google Scholar
10. Oshitani, H: Lessons learned from international responses to severe acute respiratory syndrome (SARS). Environmental Health and Preventive Medicine 2005;10(5):251–254.CrossRefGoogle ScholarPubMed
11. Monson, RR: Occupational Epidemiology. 2d ed. Boca Raton, Florida: CRC Press 1990, pp 1–12.Google Scholar
12. Lindeboom, GA: Inleding to de geschiedenis der geneeskunde. [Introduction in the history of medicine]. 7th ed. Rotterdam, The Netherlands: Erasmus Publishing, pp 251–252.Google Scholar
13. Zylberstein, JC (ed): Rapport de la Commission d'Enquête sur l'étét des Connaisssances Scientifiques et les Actions Menées à l'égard de la Transmission du SIDA. Paris: Union Générale d'Editions, 1993, p 559.Google Scholar
14. Fan, HY, Conner, RF, Villareal, LP: AIDS: Science and Society. Fifth Edition. Sudbury, Massachusetts: Jones and Bartlett Publishers, 2007, p 249.Google Scholar
15. Tucker, JB: Scourge: The Once and Future Threat of Smallpox. New York: Atlantic Montly Press, 2001, p 291.Google Scholar
16. Kolata, G: Flu:The Story of the Great Influenza Pandemic of 1918 and the Search for the Virus that Caused It. New York: Simon & Schuster Adult Publishing Group, 2001, p 352.Google Scholar
17. Barry, JM: The Great Influenza: The Epic Story of the Deadliest Plague in History. Viking Books: New York, 2004, p 546.Google Scholar
18. Johnson, NP, Mueller, J: Updating the accounts: Global mortality of the 1918–1920 “Spanish” influenza pandemic. Bull Hist Med 2002;76;105–115.CrossRefGoogle ScholarPubMed
19. US Homeland Security Council: National Strategy for Pandemic Influenza. Implementation Plan. One Year Summary. Washington: DHS, 2007, p 36.Google Scholar
20. Gorner, P: New England Journal of Medicine Eases Conflict-of-Interest Policy for Authors. Chicago Tribune, 13 June 2002.Google Scholar
21. Topol, EJ, Nurok, M, Ratain, MJ, Sheridan, ME, Lo, B, Wolf, L, Mccrary, SV, Mccullough, LB, Brody, BA, Martin, JB, Kasper, DL: Conflict-of-interest policies. N Engl J Med 2001;344:1017–1018.Google ScholarPubMed
22. Parascandola, M: A turning point for conflicts of interest: The controversy over the National Academy of Sciences' First Conflicts of Interest Disclosure Policy. JCO 2007;25:3774–3779.CrossRefGoogle ScholarPubMed
23. Rothman, DJ, McDonald, WJ, Berkowitz, CD: Professional medical associations and their relationships with industry: A proposal for controlling conflict of interest. JAMA 2009;301:1367–1372.CrossRefGoogle ScholarPubMed
24. Tripathi, S: Not just for profit, or not just? As the Swiss drug company behind Tamiflu comes under pressure to allow clones, Salil Tripathi asks whether bargain-basement copies really help. The Guardian 04 November 2005.Google Scholar
25. Russell, S: Biotech firm wants to regain control of avian flu drug. Gilead says deal with Roche Inc. threatens Tamiflu's production. San Francisco Chronicle 24 June 2005.Google Scholar
26. Wachman, R: Roche poised for £1 bn deal on bird flu drugs. Companies boost production of anti-virals for national stockpiles. The Observer UK 27 October 2005.Google Scholar
27. Mathiason, N: Roche makes a killing. As panic spreads over the avian flu, the Swiss pharmaceutical giant is accused of putting profits before people. The Observer UK 23 October 2005.Google Scholar
28. Beaumont, P, Hinsliff, G: WMD: How it went wrong. Since David Kay's bombshell last week, intelligence experts are revealing the truth behind Saddam's threat to the West. The Observer 01 February 2004.Google Scholar
29. Lean, G, Owen, J: Donald Rumsfeld makes $5m killing on bird flu drug. The Independent, UK 12 March 2006.Google Scholar
29. Hayden, FG, Palese, P: Influenza Virus In: Richmman, DD, Whitley, RJ, Hayden, FG (eds). Clinical Virology. New York: Churchill Livingstone, 1997, pp 911–942.Google Scholar
30. Seynaeve, G: Pandemic Influenza Preparedness Planning. Report on the 4th Joint EC/ECDC/WHO Workshop on Pandemic Influenza Preparedness. Luxembourg, 25–27 September 2007. Copenhagen, Denmark, WHO Regional Office for Europe, 2007, p 46.Google Scholar
31. Assaad, F, Borecka, I: Nine-year study of WHO virus reports on fatal virus infections. Bull WHO 1977;55(4):445–453.Google Scholar
32. Assaad, F, Cockburn, WC: A seven-year study of WHO virus laboratory reports on respiratory virusses. Bull WHO 1974;51(5):427–445.Google Scholar
33. Christie, AB: Infectious Diseases. Epidemiology and Clinical Practice. 2d ed. New York: Churchil Livingstone, 1974, pp 316, 326–331, 336–338.Google Scholar
34. Boix, E: Grippe. In: Brissaud, E, Pinard, A, Reclus, P (eds), Pratique Médico-Chirurgicale. Tome III. Paris: Masson et Cie Editeurs, 1907, pp 371–394.Google Scholar
36. Rubin, EH: Diseases of the Chest. With Emphasis on X-Ray Diagnosis. Philadelphia: WB Saunders, 1948, pp 102–108.Google Scholar
37. Friedwald, WF: Influenza. In: Harrison, TR (edit), Principles of Internal Medicine. Second Edition. New York, Toronot, London: McGraw-Hill Book Cy, 1954, pp 1079–1081.Google Scholar
38. Lyght, CE (ed): The Merck Manual of Diagnosis and Therapy. 9th edition. Rahway, NJ: Merck & Co Inc., 1956, pp 866–870.Google Scholar
39. Horsfall, FL: Influenza. In: Cecil, RL, Loeb, RF: A Textbook of Medicine. 9th Ed. Philadelphia, London: W.B. Saunders, 1957, pp 9–13.Google Scholar
40. Lilington, GA, Jamplis, RW: A Diagnostic Approach to Chest Diseases: Differential Diagnoses based on Roentgenographic Patterns. Baltimore: Williams &Wilkins Cy, 1965, pp 163–164, 206–207, 299–301, 309–311, 791–794.Google Scholar
41. Mosby's Comprehensive Review of Nursing. 7th Ed. Saint Louis: The C.V. Mosby Cy, 1969, pp 443, 458.Google Scholar
42. Beland, IL: Clinical Nursing: Pathophysiological and Psychosocial Approaches. 2d Ed. London: Collier-Macmillan Ltd, 1970, pp 110–149, 297.Google Scholar
43. Brainerd, H, Krupp, MA, Chatton, MJ, Margen, S: Current Diagnosis and Treatment. Los Altos, California: Lange Medical Publications, 1970, pp 677–678.Google Scholar
44. Wagner, RB: Influezna. In: Wintrobe, MM (ed): Harrison's Principles of Internal Medicine. 6th Ed. New York, Toronto, London: McGraw-Hill Book Cy, 1970, pp. 956–959.Google Scholar
45. Daven Port, FM: Influenza Viruses. In: Evans, AS: Viral Infections of Humans. Epidemiology and Control. London, New York, Sydney, Toronto: John Wiley & Sons, 1976, pp 273–296.CrossRefGoogle Scholar
46. Parlemuter, L, Cenac, A: Dictionnaire pratique de Médecine Clinique. Paris: Masson, 1977, pp 52–60.Google Scholar
47. Simon, HV: Respiratory Viral Infections. In: Medicine. Scientific American, 1994, pp 1–8.Google ScholarPubMed
48. Tierney, LM, McPhee, SJ, Papadakis, MA (ed): Current Medical Diagnosis and Treatment. 39th Ed. New York: Lange Medical Books/McGraw-Hill, 2000, pp 1321–1323.Google Scholar
49. Hampton, T :Drug, vaccine research target avian flu. JAMA 2007;297:1179–1180.CrossRefGoogle ScholarPubMed
50. MacDonald, N: H1N1 influenza vaccine: Global access for a global problem. CMAJ 2009;181(3–4):123.CrossRefGoogle ScholarPubMed
51. National Strategy for Pandemic Influenza: Implementation Plan. One Year Summary. Homeland Security Council, July 2007, p 36.Google Scholar
52. De Goojer, AC: De Spaanse griep van '18. [The Spanish Flu of '18.]. Amsterdam, The Netheralnds: Philips-Duphar, 1978, p 235.Google Scholar
43. Plotkin, JB, Dushoff, J: Codon bias and frequency-dependent selection on the hemagglutinin epitopes of influenza A virus. Proc Nat Acad 2003;100(12):7152–7157.CrossRefGoogle ScholarPubMed
54. Palese, P, Tumpey, TM, Garcia-Sastre A:What can we learn from econstructing the extinct 1918 pandemic influenza virus? Immunity 2006;24(2):121–124.CrossRefGoogle Scholar
55. Shann, F: Pneumococcus and Influenza. In: [Need authors or editors] Modern Vaccines. Current Practice and New Approaches. A Lancet Review. London, Melbourne, Auckland: Edward Aarnold, 1990, pp 87–90.Google Scholar
56. Ajjan, N: La vaccination. 2d Ed. Paris: Institut Mériex, 1985, pp 64–65, 124–126, 136–137, 263–276.Google Scholar
57. Vogt, D: Schutzimpfungen. In: Theopold, W (editor), Präventive Medizin. Frankfurt Am Main, Germany: Umschau Verlag, 1970, pp 153.Google Scholar
58. De Wit, GA, Verweij, A, Van Baal, PHM, Vijgen, SMC, Van Den Berg, M, Busch, MCM, Barnhoorn, MJM, Schuit, AJ: Economic evaluation of prevention: Further evidence. RIVM Report 270091004/2007. Available at http://rivm.openrepository.com/rivm/bitstream/10029/16478/1/270091004.pdf. Accessed 18 December 2009.Google Scholar
59. US Preventive Services Task Force: Guide to Clinical Preventive Services. 2d Ed. Baltimore: Williams & Wilkins, 1996, pp 791–794.Google Scholar
60. Turner, D, Wailoo, A, Nicholson, K, Coopers, N, Sutton, A, Abrams, K: Systematic review and economic decision modelling for the prevention and treatment of influenza A and B. Health Technol Assess 2003;7(35):286.CrossRefGoogle ScholarPubMed
61. Benenson, AS: Infectious Diseases. In: Levine, S, Lilienfeld, AM (edit), Epidemiology and Health Policy. New York-London: Tavistock Publications, 1987.Google Scholar
62. Gatherer, D: The 2009 H1N1 influenza outbreak in its historical context. Journal of Clinical Virology 2009;45:174–178.CrossRefGoogle ScholarPubMed
63. Chowell, G, Bertozzi, SM, Colchero, MA, Lopez-Gatell, H, Alpuche-Aranda, C, Hernandez, M, Miller, MA: Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med 2009;361:674–679.CrossRefGoogle ScholarPubMed
64. Centers for Disease Control and Prevention: Swine influenza A (H1N1) infection in two children—Southern California, March–April 2009. MMWR 2009;58:400–402.Google Scholar
65. Zimmer, SM, Burke, DS: Historical perspective—Emergence of influenza A (H1N1) viruses. N Engl J Med 2009;361:279–285CrossRefGoogle ScholarPubMed
66. Shinde, V, Bridges, CB, Uyeki, TM, Shu, B, Balish, A, Xu, Xiyan, Lindstrom, S, Gubareva, LV, Deyde, V, Garten, RJ, Harris, M, Gerber, S, Vagasky, S, Smith, F, Pascoe, N, Martin, K, Dufficy Deborah, Ritger K, Conover, C, Quinlisk, P, Klimov, A, Bresee, JS, Finellie, L: Triple-Reassortant Swine Influenza A (H1) in Humans in the United States, 2005–2009. N Engl J Med 2009;360:2616–2625.CrossRefGoogle ScholarPubMed
67. Pariente, J: Pour Marc Gentilini, on assiste à une “pandémie de l'indécence”. Le Monde, France, August 6, 2009.Google Scholar
68. Hak, E, Meijboom, MJ, Buskens, E: Modelling the health-economic impact of the next influenza pandemic in The Netherlands. Vaccine 2006;24:6756–6760.CrossRefGoogle ScholarPubMed
69. Sondervorst, FA: Geschiedenis van de geneeskunde in België. [History of Medicine in Belgium]. Brussel, Belgium: Elsevier, 1981, p 230.Google Scholar
70. Kovner, AVR, Martin, SP: Community Health and Medical Care. New York, San Francisco, London: Grune & Stratton Inc., 1978, p 483.Google Scholar